The next-generation hematology platform builds on the XN-Series with higher throughput, enhanced analytics and modular workflow support for high-complexity laboratories. ...
Recent advancements around pTau217 assays are drawing significant attention for their ability to detect amyloid pathology through minimally invasive blood testing...
The introduction of proton therapy at Tam Anh General Hospital marks a turning point for cancer care in Southeast Asia ...
The new facility expands access to fertility assessment, IVF-related services, embryology and laboratory capabilities for couples in Singapore. ...
RAMP UP programme with Hitachi High-Tech America supports electronic genome mapping studies in AML and MDS ...
Lancet-published Integral-1 results support nacubactam’s potential as a new option against drug-resistant Gram-negative infections ...
IVDR-compliant PCR test supports the detection of 11 clinically relevant gastrointestinal pathogens from 1 sample...
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases....
The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings. ...
The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...
